These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 34310699)

  • 1. Psoriasis-related treatment exposure and hospitalization or in-hospital mortality due to COVID-19 during the first and second wave of the pandemic: cohort study of 1 326 312 patients in France.
    Penso L; Dray-Spira R; Weill A; Zureik M; Sbidian E
    Br J Dermatol; 2022 Jan; 186(1):59-68. PubMed ID: 34310699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence, risk and severity of SARS-CoV-2 infections in psoriasis patients receiving conventional systemic, biologic or topical treatment during the COVID-19 pandemic: a cross-sectional cohort study (PsoCOVID).
    Kwee KV; Murk JL; Yin Q; Visch MB; Davidson L; de Jong EMGJ; van den Reek JMPA; Tjioe M
    J Dermatolog Treat; 2023 Dec; 34(1):2161297. PubMed ID: 36545844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristic of chronic plaque psoriasis patients treated with biologics in Italy during the COVID-19 Pandemic: Risk analysis from the PSO-BIO-COVID observational study.
    Talamonti M; Galluzzo M; Chiricozzi A; Quaglino P; Fabbrocini G; Gisondi P; Marzano AV; Potenza C; Conti A; Parodi A; Piaserico S; Bardazzi F; Argenziano G; Rongioletti F; Stingeni L; Micali G; Loconsole F; Rossi MT; Bongiorno MR; Feliciani C; Rubegni P; Amerio P; Fargnoli MC; Pigatto P; Savoia P; Nisticò SP; Giustini S; Carugno A; Cannavo' SP; Rech G; Prignano F; Offidani A; Lombardo M; Zalaudek I; Bianchi L; Peris K; ; Balestri R ; Bernardini N ; Belloni Fortini A ; Burlando M ; Caldarola G ; Campione E ; Cattaneo A ; Dapavo P ; Dastoli S ; De Simone C ; Di Nuzzo S ; Diotallevi F ; Fierro MT ; Franchi C ; Esposito M ; Foti C ; Gambini DM ; Gambardella A ; Girolomoni G ; Giunta A ; Guarneri C ; Gualdi G ; Hansel K ; Megna M ; Mugheddu C ; Musumeci ML ; Patrizi A ; Pellacani G ; Richetta AG ; Rosi E ; Sacchelli L ; Tiberio R ; Tilotta G ; Trovato E ; Venturini M ; Vezzoni R
    Expert Opin Biol Ther; 2021 Feb; 21(2):271-277. PubMed ID: 33216643
    [No Abstract]   [Full Text] [Related]  

  • 4. Tumor necrosis factor inhibitors are associated with a decreased risk of COVID-19-associated hospitalization in patients with psoriasis-A population-based cohort study.
    Kridin K; Schonmann Y; Damiani G; Peretz A; Onn E; Bitan DT; Cohen AD
    Dermatol Ther; 2021 Jul; 34(4):e15003. PubMed ID: 34033207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization and Mortality in Patients with Psoriasis: A Population-Based Study.
    Kridin K; Schonmann Y; Tzur Bitan D; Damiani G; Peretz A; Weinstein O; Cohen AD
    Am J Clin Dermatol; 2021 Sep; 22(5):709-718. PubMed ID: 34060006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with adverse COVID-19 outcomes in patients with psoriasis-insights from a global registry-based study.
    Mahil SK; Dand N; Mason KJ; Yiu ZZN; Tsakok T; Meynell F; Coker B; McAteer H; Moorhead L; Mackenzie T; Rossi MT; Rivera R; Mahe E; Carugno A; Magnano M; Rech G; Balogh EA; Feldman SR; De La Cruz C; Choon SE; Naldi L; Lambert J; Spuls P; Jullien D; Bachelez H; McMahon DE; Freeman EE; Gisondi P; Puig L; Warren RB; Di Meglio P; Langan SM; Capon F; Griffiths CEM; Barker JN; Smith CH;
    J Allergy Clin Immunol; 2021 Jan; 147(1):60-71. PubMed ID: 33075408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistence of apremilast in moderate-to-severe psoriasis: a real-world analysis of 14 147 apremilast- and methotrexate-naive patients in the French National Health Insurance database.
    Sbidian E; Billionnet C; Weill A; Maura G; Mezzarobba M
    Br J Dermatol; 2020 Mar; 182(3):690-697. PubMed ID: 31021438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. International Changes in COVID-19 Clinical Trajectories Across 315 Hospitals and 6 Countries: Retrospective Cohort Study.
    Weber GM; Zhang HG; L'Yi S; Bonzel CL; Hong C; Avillach P; Gutiérrez-Sacristán A; Palmer NP; Tan ALM; Wang X; Yuan W; Gehlenborg N; Alloni A; Amendola DF; Bellasi A; Bellazzi R; Beraghi M; Bucalo M; Chiovato L; Cho K; Dagliati A; Estiri H; Follett RW; García Barrio N; Hanauer DA; Henderson DW; Ho YL; Holmes JH; Hutch MR; Kavuluru R; Kirchoff K; Klann JG; Krishnamurthy AK; Le TT; Liu M; Loh NHW; Lozano-Zahonero S; Luo Y; Maidlow S; Makoudjou A; Malovini A; Martins MR; Moal B; Morris M; Mowery DL; Murphy SN; Neuraz A; Ngiam KY; Okoshi MP; Omenn GS; Patel LP; Pedrera Jiménez M; Prudente RA; Samayamuthu MJ; Sanz Vidorreta FJ; Schriver ER; Schubert P; Serrano Balazote P; Tan BW; Tanni SE; Tibollo V; Visweswaran S; Wagholikar KB; Xia Z; Zöller D; ; Kohane IS; Cai T; South AM; Brat GA
    J Med Internet Res; 2021 Oct; 23(10):e31400. PubMed ID: 34533459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nineteen months into the pandemic, what have we learned about COVID-19-related outcomes in patients with psoriasis?
    Kridin K; Schonmann Y; Onn E; Bitan DT; Weinstein O; Shavit E; Cohen AD
    J Cosmet Dermatol; 2022 Dec; 21(12):6549-6553. PubMed ID: 36056782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic diseases, health conditions and risk of COVID-19-related hospitalization and in-hospital mortality during the first wave of the epidemic in France: a cohort study of 66 million people.
    Semenzato L; Botton J; Drouin J; Cuenot F; Dray-Spira R; Weill A; Zureik M
    Lancet Reg Health Eur; 2021 Sep; 8():100158. PubMed ID: 34308411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the COVID-19 pandemic and a national lockdown on hospitalizations for stroke and related 30-day mortality in France: A nationwide observational study.
    Gabet A; Grave C; Tuppin P; Chatignoux E; Béjot Y; Olié V
    Eur J Neurol; 2021 Oct; 28(10):3279-3288. PubMed ID: 33738913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics, Management, and Case-Fatality of Patients Hospitalized for Stroke with a Diagnosis of COVID-19 in France.
    Gabet A; Grave C; Chatignoux E; Tuppin P; Béjot Y; Olié V
    Neuroepidemiology; 2021; 55(4):323-330. PubMed ID: 34167111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of Hip Fractures in France During the First COVID-19 Lockdown in Spring 2020.
    Paccou J; Lenne X; Ficheur G; Theis D; Cortet B; Bruandet A
    JAMA Netw Open; 2021 Nov; 4(11):e2134972. PubMed ID: 34787657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiologic study in a real-world analysis of patients with treatment for psoriasis in the French national health insurance database.
    Grodner C; Sbidian E; Weill A; Mezzarobba M
    J Eur Acad Dermatol Venereol; 2021 Feb; 35(2):411-416. PubMed ID: 32364321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excess Mortality Among Patients Hospitalized During the COVID-19 Pandemic.
    Sabbatini AK; Robicsek A; Chiu ST; Gluckman TJ
    J Hosp Med; 2021 Oct; 16(10):596-602. PubMed ID: 34328844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: national derivation and validation cohort study.
    Clift AK; Coupland CAC; Keogh RH; Diaz-Ordaz K; Williamson E; Harrison EM; Hayward A; Hemingway H; Horby P; Mehta N; Benger J; Khunti K; Spiegelhalter D; Sheikh A; Valabhji J; Lyons RA; Robson J; Semple MG; Kee F; Johnson P; Jebb S; Williams T; Hippisley-Cox J
    BMJ; 2020 Oct; 371():m3731. PubMed ID: 33082154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of the SARS-COV-2 outbreak on epidemiology and management of major traumain France: a registry-based study (the COVITRAUMA study).
    Moyer JD; James A; Gakuba C; Boutonnet M; Angles E; Rozenberg E; Bardon J; Clavier T; Legros V; Werner M; Mathais Q; Ramonda V; Le Minh P; Berthelot Y; Colas C; Pottecher J; Gauss T;
    Scand J Trauma Resusc Emerg Med; 2021 Mar; 29(1):51. PubMed ID: 33752728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demographics, clinical characteristics, and outcomes of 27,256 hospitalized COVID-19 patients in Kermanshah Province, Iran: a retrospective one-year cohort study.
    Hesni E; Sayad B; Khosravi Shadmani F; Najafi F; Khodarahmi R; Rahimi Z; Bozorgomid A; Sayad N
    BMC Infect Dis; 2022 Mar; 22(1):319. PubMed ID: 35361161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biologics increase the risk of SARS-CoV-2 infection and hospitalization, but not ICU admission and death: Real-life data from a large cohort during red-zone declaration.
    Damiani G; Pacifico A; Bragazzi NL; Malagoli P
    Dermatol Ther; 2020 Sep; 33(5):e13475. PubMed ID: 32356577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.